After a challenging few months, investors are skeptical at start of October. But we remain constructive on stocks into year-end, even with near-term risks.
The chip maker gets a lift from Goldman Sachs' conviction buy list.
Almost there. Third quarter earnings season is practically upon us and will kick off late next week.
Knowing that we are due for a big bounce means buying now, before it happens, rather than waiting for confirmation and missing out on great prices.
Despite the good news of a deal in Congress to avoid a government shutdown, early market indications are weak.
It's possible these are just blips, but along with the dollar, bonds, oil itself and the Transports, this is where my focus is.
This small-cap is developing a promising new gastrointestinal disease-fighting drug and has one already on the market, making it a great options play.
A concentrated position in the right stock at the right time is how you make exceptional profit. Here are the steps that pro traders employ to rack up huge gains.
Despite a high volume of noise, inflation remains the primary macro driver for markets, while a government shutdown could put the Fed on an automatic 'structural pause.'
These names provide shareholders with potential growth in addition to their dividends.